Modified FELL tetrapeptides showed that strong PDE4B inhibition in vitro did not reliably predict anti-inflammatory effects ...

Genome analysis and laboratory assays found antioxidant, anti-inflammatory, antidiabetic and antiproliferative activity in a ...

US genomics technology firm Element Biosciences, backed by Samsung Electronics as its largest shareholder, is kicking off a ...

Target workflow instruments, drug discovery and North America; use competitive, patent and partnership insights to sharpen market positioning and go-to-market strategies.Dublin, Oct. 20, 2026 (GLOBE ...

Key Concerns and Clinical Evidence / cancer, CAR-T, CD19-Targeted Therapies, Hematology, large B-cell lymphoma ...

INTU is set to acquire Sequence to enhance AI-powered revenue management, automate complex billing workflows and strengthen ...

With both CAR T-cell therapy and bispecific antibodies now available in early relapse, Adam D. Cohen, MD, director of Myeloma ...

Graduate students in Penn State's College of Agricultural Sciences contributed to the first complete genome sequence of a ...

Acinetobacter baumannii is a major nosocomial pathogen with a remarkable capacity to adapt to both hospital and host ...

Residential roofing work begins with an operational step that determines every subsequent action. BC Exteriors documents roof inspection and assessment as the starting point for its residential ...

What Comes Next? Treatment Sequencing in Advanced Urothelial Carcinoma / antibody-drug conjugate, cancer, cancer care, Cancer ...

Intuit surges 6.63% today to $331.06 after acquiring Sequence, boosting its AI-driven revenue solutions for businesses.